Chair
Executive Committee
Vice Chair
Pam Randhawa
Founder & CEO of Empiriko
Treasurer
Michael O’Hara
Partner, Deloitte
Counsel
Larry Wittenberg
Senior Partner, Technology Companies & Life Sciences Group at Goodwin
Clerk
Chris Garabedian
Chairman and CEO of Xontogeny
Immediate Past Chair
David Lucchino
Co-founder, President and Chief Executive Officer of Frequency Therapeutics
Directors
Abbie Celniker, PH.D.
Partner at Third Rock Ventures
Laurie Bartlett Keating
SVP, General Counsel and Secretary of Alnylam Pharmaceuticals, Inc.
Udit Batra
Chief Executive Officer of MilliporeSigma
Cheryl Blanchard
President & CEO of Anika Therapeutics, Inc.
Melissa Bradford-Klug
CEO, Mayfield Pharmaceuticals
Timothy P. Clackson
President, and EVP of R&D, of Xilio Therapeutics
Chip Clark
President and Chief Executive Officer, Genocea Biosciences, Inc.
Sharon Cload
Vice President, Discovery Biotherapeutics, Bristol Myers Squibb
Jason Cole
Chief Legal Officer of Bluebird Bio
Christopher de Souza
Director at Broadview Ventures
John Dunlop
Vice President, Neuroscience Research at Amgen
Jeff Elton
CEO of Concerto HealthAi
Barbara S. Fox
CEO, Rheos Medicines
Gary Gillheeney
President and CEO at Organogenesis Inc.
Robert Gottlieb
Principal, RMG Associates
Jose-Carlos Gutierrez-Ramos, Ph.D.
Vice President of Discovery, AbbVie
Scott H. Gillis
President of Pericor Science, Inc.
Sue Hager
Chief Communications Officer, SVP Corporate Affairs & Citizenship, EQRx
Martin Heidecker
Managing Director, Boehringer Ingelheim Venture Fund USA
Amit K. Sachdev
EVP, Chief Regulatory Officer at Vertex
Ed Kaye
CEO at Stoke Therapeutics
Chris Leibman
Senior Vice President Value and Access at Biogen
Mark Leuchtenberger
Executive Chairmain, Aleta Biotherapeutics
Lizabeth Leveille
Associate Vice President and Head, Boston Innovation Hub of BD&L Merck Research Laboratories
Liz Lewis
Head of Global Oncology Patient Value, Policy and Access at Takeda Oncology
Alice Lin Pomponio
Advisor at Red Sky Partners; Founder and Managing Director at Accendo
Joel Marcus
CEO of Alexandria Real Estate Equities, Inc.
David Meeker
President & CEO of Rhythm Therapeutics
Gilmore O’Neill
Executive Vice President, R&D and Chief Medical Officer at Sarepta
William P. McDermott
Partner at McDermott, Quilty & Miller LLP
Cindy Perettie
CEO, Foundation Medicine
Adelene Perkins
CEO & Chair at Infinity Pharmaceuticals
Mark R. Bamforth
President & CEO, Arranta Bio
Chandra Ramanathan
Vice President & Head, East Coast Innovation Center
Eric Rasmussen
Vice President, Government Relations and Public Affairs at Sunovion
Richard Russell
President of Minerva Neurosciences
Bill Sibold
Executive Vice President and Head of Sanofi Genzyme
Barbara Sosnowski
VP and ERDI Head at Pfizer
Kumar Srinivasan
Vice-President, Scientific Partnering and Alliances and Site Head, R&D Boston at AstraZeneca
Tamar Thompson
Vice President, U.S. Government Affairs, Alexion Pharmaceuticals, Inc.
Rehan Verjee
President, EMD Serono, Global Head of the Innovative Medicine Franchises, Member of the Healthcare Executive Committee, Merck KGaA, Darmstadt, Germany
